Found: 22
Select item for more details and to access through your institution.
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1129765
- By:
- Publication type:
- Article
Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 12, p. 3096, doi. 10.1093/cid/ciz1198
- By:
- Publication type:
- Article
Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 12, p. 2067, doi. 10.1093/cid/ciy818
- By:
- Publication type:
- Article
Bivalent Coronavirus Disease 2019 Vaccine Antibody Responses to Omicron Variants Suggest That Responses to Divergent Variants Would Be Improved With Matched Vaccine Antigens.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 4, p. 439, doi. 10.1093/infdis/jiad111
- By:
- Publication type:
- Article
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 382, doi. 10.3390/vaccines8030382
- By:
- Publication type:
- Article
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
- Published in:
- Emerging Infectious Diseases, 2022, v. 28, n. 4, p. 828, doi. 10.3201/eid2804.212037
- By:
- Publication type:
- Article
Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx023
- By:
- Publication type:
- Article
Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 2, doi. 10.1186/s12977-014-0086-8
- By:
- Publication type:
- Article
HIV Escape From Peptide Fusion Inhibitors.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants.
- Published in:
- PLoS Pathogens, 2023, v. 19, n. 11, p. 1, doi. 10.1371/journal.ppat.1011788
- By:
- Publication type:
- Article
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248348
- By:
- Publication type:
- Article
Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175733
- By:
- Publication type:
- Article
Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222436
- By:
- Publication type:
- Article
D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1010468
- By:
- Publication type:
- Article
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 5, p. 1, doi. 10.1111/irv.13152
- By:
- Publication type:
- Article
Antibodies to the A27 Protein of Vaccinia Virus Neutralize and Protect against Infection but Represent a Minor Component of Dryvax Vaccine—Induced Immunity.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 7, p. 1026, doi. 10.1086/520936
- By:
- Publication type:
- Article
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 12, p. 2485, doi. 10.3390/v13122485
- By:
- Publication type:
- Article
Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors.
- Published in:
- Viruses (1999-4915), 2012, v. 4, n. 12, p. 3859, doi. 10.3390/v4123859
- By:
- Publication type:
- Article
Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149149
- By:
- Publication type:
- Article
Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128562
- By:
- Publication type:
- Article
Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 6, p. 1, doi. 10.1371/journal.ppat.1002081
- By:
- Publication type:
- Article